You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Drug Price Trends for levetiracetam


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for levetiracetam

Average Pharmacy Cost for levetiracetam

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LEVETIRACETAM 1,000 MG TABLET 82009-0124-60 0.14469 EACH 2024-11-20
LEVETIRACETAM 750 MG TABLET 82009-0123-05 0.09537 EACH 2024-11-20
LEVETIRACETAM 500 MG TABLET 82009-0122-05 0.06077 EACH 2024-11-20
LEVETIRACETAM 250 MG TABLET 82009-0121-05 0.04537 EACH 2024-11-20
LEVETIRACETAM ER 750 MG TABLET 75834-0246-60 0.18185 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for levetiracetam

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LEVETIRACETAM 100MG/ML INJ Sagent Pharmaceuticals 25021-0780-05 10X5ML 3.52 2024-05-01 - 2029-04-30 FSS
LEVETIRACETAM 1000MG/100ML 0.82% NACL INJECT Mylan Institutional LLC 67457-0265-10 10X100ML 117.70 2023-10-12 - 2028-09-28 FSS
LEVETIRACETAM 500MG/100ML 0.82% NACL INJECTIO Mylan Institutional LLC 67457-0255-10 10X100ML 69.26 2023-09-29 - 2028-09-28 FSS
LEVETIRACETAM 1500MG/100ML 0.82% NACL INJECT Mylan Institutional LLC 67457-0266-10 10X100ML 155.78 2024-01-01 - 2028-09-28 FSS
LEVETIRACETAM 1000MG/100ML 0.82% NACL INJECT Mylan Institutional LLC 67457-0265-10 10X100ML 99.48 2024-01-01 - 2028-09-28 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.